Adding postpolypectomy surveillance to fecal immunochemical testing is not cost-effective
1. Fecal immunochemistry testing (FIT) screening alone reduced mortality from colorectal cancer (CRC). 2. Adding postpolypectomy surveillance colonoscopy was not ...